The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-U.S. Ebola 'czar' starts work, drugmakers launch vaccine drive

Wed, 22nd Oct 2014 15:53

(Adds human testing of possible vaccine, paragraphs 9-10, NewJersey patient cleared, paragraph 17)

WASHINGTON, Oct 22 (Reuters) - The new U.S. Ebola "czar"starts work on Wednesday as the Obama administration ramps upits response to the potential spread of the virus, anddrugmakers started a project to accelerate development of avaccine and produce millions of doses.

As the administration boosted airport screening measures inresponse to criticism that it was slow to act against Ebola, aPentagon emergency Ebola medical team was scheduled to begintraining at Fort Sam Houston in San Antonio, Texas.

The virus has killed more than 4,500 people, predominantlyin three impoverished West African countries, in the worstoutbreak of the disease since it was identified in 1976.

U.S. President Barack Obama was set to hold a meeting onWednesday with Ron Klain, his new Ebola response coordinator, amid rising Republican criticism ahead of congressionalelections next month.

Klain, a lawyer and veteran Democratic political operative,was expected to improve coordination between the federalgovernment and the states after three cases were diagnosed inthe United States, all in Texas; Liberian Thomas Eric Duncan,who died on Oct. 8 in Dallas, and two nurses who treated him.

Leading drugmakers said on Wednesday that they planned todevelop an Ebola vaccine and produce millions of doses of themost effective experimental product for use next year.

The World Health Organization said it hopes tens of thousandof people in Africa, including front-line healthcare workers,can start receiving vaccines beginning in January.

U.S. drugmaker Johnson & Johnson announced that itaims to produce 1 million doses of its two-step vaccine nextyear, and said it has discussed collaboration with Britain'sGlaxoSmithKline, which is working on a rival vaccine.

Human testing of a second "investigational" Ebola vaccine isunder way at the U.S. National Institutes of Health's ClinicalCenter in Maryland, NIH said on Wednesday. Testing on a firstpossible vaccine began last month and initial data was expectedby the end of the year.

"The need for a vaccine to protect against Ebola infectionis urgent," said Dr. Anthony Fauci, director of the NationalInstitute of Allergy and Infectious Diseases. He said thevaccine, called VSV-ZEBOV, was "promising."

The U.S. Defense Department's emergency medical team -including five infectious disease doctors, 20 critical carenurses and five trainers who are experts in infectious diseaseprotocols - will gather in Texas on Wednesday to start threedays of training, the Pentagon said.

NO TRAVEL BAN

The Obama administration has ratcheted up its response toEbola but so far has stopped short of a travel ban from WestAfrican countries hit by Ebola demanded by some lawmakers.

The Department of Homeland Security said on Tuesday thattravelers from the three countries at the center of the epidemic- Liberia, Sierra Leone and Guinea - would be funneled to one offive major U.S. airports conducting enhanced screening for thevirus. The restrictions on passengers whose trips originated inthose countries were due to go into effect on Wednesday.

Affected travelers will have their temperatures checked forsigns of a fever that may indicate Ebola infection, among otherprotocols, at New York's John F. Kennedy, New Jersey's Newark,Washington Dulles, Hartsfield-Jackson Atlanta, and Chicago'sO'Hare international airports, officials said.

Two travelers from Liberia were under observation inhospitals in Chicago on Wednesday after they reported symptoms during screening at O'Hare on Tuesday.

One, a child, reportedly vomited on the flight to Chicago,health officials said. A physician at the hospital where thechild was taken said doctors suspect the patient does not haveEbola but was isolated as a precaution.

In New Jersey, a Liberian passenger detained at NewarkLiberty airport on Tuesday appears to be symptom free, GovernorChris Christie said at a news confrence. "There is no indicationthat he has been infected with Ebola," Christie said.

A Reuters/Ipsos online poll released on Tuesday showed thatnearly three-fourths of 1,602 Americans surveyed favored a U.S.ban on civilian air travel in and out of the three countries.

But Elhadj As Sy, secretary general of the InternationalFederation of Red Cross and Red Crescent Societies (IFRC), onWednesday said such restrictions would not effectively curbEbola.

"It (Ebola) creates a lot of fear and extreme panic thatsometimes lead to very irrational type of behaviors andmeasures, like closing borders, canceling flights, isolatingcountries, etc.," Sy told reporters in Beijing, where the IFRCwas holding a conference. "Those are not solutions."

A group of some 50 Cuban doctors and nurses arrived inLiberia on Wednesday to help treat patients.

The two U.S. nurses who contracted Ebola after treating Thomas Duncan were both improving. The U.S. National Institutesof Health (NIH) upgraded the medical condition Nina Pham onTuesday to good from fair. The other, Amber Vinson, is weak butrecovering, her mother said.

NBC freelance cameraman Ashoka Mukpo, an American whocontracted Ebola while working in West Africa, is free of thevirus and will leave the Nebraska Medical Center on Wednesday,the hospital said. (Additional reporting by James Harding Giahyue in Monrovia,Daniel Trotta in Havana, Ben Hirschler in London, Will Dunhamand Susan Heavey in Washington, Barbara Goldberg in New York andJulie Steenhuysen in Chicago; Writing by Jim Loney; Editing byJeffrey Benkoe and Jonathan Oatis)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.